We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5393:TSENichias Corporation Analysis

Data as of 2026-03-15 - not real-time

¥8,846.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nichias Corporation is currently trading well above its short‑term moving averages, confirming a bullish price bias. The 20‑day and 50‑day SMAs sit beneath the market price, while the 200‑day SMA remains supportive. Momentum indicators show a neutral stance, with the RSI lingering in the mid‑50s. The MACD histogram is negative, hinting at short‑term weakening despite the overall bullish trend. Volume has been on a downward trajectory, which tempers the upside momentum. Volatility remains elevated, reflecting sizable price swings.
Fundamentally, the stock’s PE multiple is comfortably below the sector average, and the payout ratio is modest, supporting dividend sustainability. Cash reserves far exceed debt, yielding a low leverage profile. However, the discounted cash‑flow model places intrinsic value well under the current market price, suggesting limited upside. The low beta underscores limited sensitivity to broader market moves, while the Greed‑driven sentiment index points to bullish investor mood. Given these mixed signals, the consensus recommendation leans toward a measured approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages
  • Negative MACD histogram indicating short‑term weakening
  • Decreasing volume dampening momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE below industry average suggesting relative cheapness
  • Strong cash position and modest leverage
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified industrial product portfolio
  • Low beta implying stability over market cycles
  • Consistent dividend yield supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-6.10%
Profit Margin12.16%
P/E Ratio18.8
ROE13.90%
ROA7.36%
Debt/Equity4.64
P/B Ratio2.5
Op. Cash Flow¥19.2B
Free Cash Flow¥8.2B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI55.2
Support¥7,849.00
Resistance¥9,715.00
MA 20¥8,720.85
MA 50¥8,087.34
MA 200¥6,301.41
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value¥2,430.48
Target Price¥9,820.00
Upside/Downside11.01%
GradeFair
TypeBlend
Dividend Yield1.85%

Risk Assessment

Beta0.29
Volatility43.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.